Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sturge-Weber Syndrome 2 Nausea 2 Vomiting 1 Tuberous Sclerosis 1 Seizures 1 Parasomnias 1 Pain 1 Neoplasms 1 Marijuana Abuse 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Cachexia 1 Breast Neoplasms 1 Arthralgia 1 Appetitive Behavior 1 Anxiety Disorders 1

Interventions

Fentanyl 18 Analgesia 14 Acupuncture Therapy 12 Zoledronic Acid 9 Therapeutics 9 Surveys and Questionnaires 9 Oxycodone 9 nabiximols 8 Morphine 8 Acetaminophen 8 Psychiatric Rehabilitation 7 Ketamine 7 Hydromorphone 7 Lidocaine 6 Ibandronic Acid 6 Radiotherapy 5 Bupivacaine 5 Analgesics, Opioid 5 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Ropivacaine 4 Music Therapy 4 Early Intervention, Educational 4 alvimopan 3 Yoga 3 Tapentadol 3 Radiosurgery 3 Radiofrequency Ablation 3 Methadone 3 Dronabinol 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡